Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
MMWR Morb Mortal Wkly Rep ; 72(16): 421-425, 2023 Apr 21.
Article in English | MEDLINE | ID: mdl-37079478

ABSTRACT

Non-Hispanic Asian (Asian) and non-Hispanic Native Hawaiian and Pacific Islander (NHPI) persons represent growing segments of the U.S. population (1). Epidemiologic cancer studies often aggregate Asian and NHPI persons (2,3); however, because Asian and NHPI persons are culturally, geographically, and linguistically diverse (2,4), subgroup analyses might provide insights into the distribution of health outcomes. To examine the frequency and percentage of new cancer cases among 25 Asian and NHPI subgroups, CDC analyzed the most current 2015-2019 U.S. Cancer Statistics data.* The distribution of new cancer cases among Asian and NHPI subgroups differed by sex, age, cancer type, and stage at diagnosis (for screening-detected cancers). The percentage of cases diagnosed among females ranged from 47.1% to 68.2% and among persons aged <40 years, ranged from 3.1% to 20.2%. Among the 25 subgroups, the most common cancer type varied. For example, although breast cancer was the most common in 18 subgroups, lung cancer was the most common cancer among Chamoru, Micronesian race not otherwise specified (NOS), and Vietnamese persons; colorectal cancer was the most common cancer among Cambodian, Hmong, Laotian, and Papua New Guinean persons. The frequency of late-stage cancer diagnoses among all subgroups ranged from 25.7% to 40.3% (breast), 38.1% to 61.1% (cervical), 52.4% to 64.7% (colorectal), and 70.0% to 78.5% (lung). Subgroup data illustrate health disparities among Asian and NHPI persons, which might be reduced through the design and implementation of culturally and linguistically responsive cancer prevention and control programs, including programs that address social determinants of health.


Subject(s)
Asian , Health Status Disparities , Native Hawaiian or Other Pacific Islander , Neoplasms , Pacific Island People , Female , Humans , Asian/statistics & numerical data , Breast Neoplasms/epidemiology , Native Hawaiian or Other Pacific Islander/statistics & numerical data , Pacific Island People/statistics & numerical data , United States/epidemiology , Neoplasms/epidemiology , Neoplasms/ethnology , Neoplasms/pathology , Centers for Disease Control and Prevention, U.S./statistics & numerical data , Social Determinants of Health/ethnology , Social Determinants of Health/statistics & numerical data , Culturally Competent Care/ethnology
2.
J Registry Manag ; 48(1): 36-43, 2021.
Article in English | MEDLINE | ID: mdl-34170894

ABSTRACT

This methodology article proposes a basic framework for assessing confidence in residential address through attribute sets of the tumor record that enable or modify spatiotemporal relationships in cancer surveillance data. A first step in assessing confidence for a statutory downstream data steward, like the Central Cancer Registry (CCR), is identifying sets of attributes whose domains are independently controlled by data stewards outside of the CCR. These include attribute sets that comprise the digital entities of person, time, and place. In this article, we describe the uncertainty in the geolocation of a cancer patient at the time of diagnosis, focusing on multiple stewardship of the cancer surveillance data. We also propose an approach to account for this uncertainty that is practical within the framework of existing cancer registry data coding, processing conventions, and legislative mandates for cancer surveillance.


Subject(s)
Neoplasms , Humans , Registries , Uncertainty
3.
Article in English | MEDLINE | ID: mdl-32326423

ABSTRACT

Rare cancers, affecting 1 in 5 cancer patients, disproportionally contribute to cancer mortality. This research focuses on liposarcoma, an understudied rare cancer with unknown risk factors and limited treatment options. Liposarcoma incident cases were identified from the U.S. Surveillance, Epidemiology, and End Result (SEER) program and the combined SEER-National Program of Cancer Registries (CNPCR) between 2001-2016. Incidence rates (age-adjusted and age-specific), 5-year survival, and the time trends were determined using SEER*stat software. Three-dimensional visualization of age-time curves was conducted for males and females. SEER liposarcoma cases represented ~30% (n = 11,162) of the nationwide pool (N = 37,499). Both sources of data showed males accounting for ~60% of the cases; 82%-86% cases were identified among whites. Age-adjusted incidence was greater among males vs. females and whites vs. blacks, whereas survival did not differ by sex and race. The dedifferentiated (57.2%), pleomorphic (64.1%), and retroperitoneal (63.9%) tumors had the worse survival. Nationwide, liposarcoma rates increased by 19%, with the annual percent increase (APC) of 1.43% (95% confidence interval (CI): 1.12-1.74). The APC was greater for males vs. females (1.67% vs. 0.89%) and retroperitoneal vs. extremity tumors (1.94% vs. 0.58%). Thus, incidence increased faster in the high-risk subgroup (males), and for retroperitoneal tumors, the low-survival subtype. The SEER generally over-estimated the rates and time trends compared to nationwide data but under-estimated time trends for retroperitoneal tumors. The time trends suggest an interaction between genetic and non-genetic modifiable risk factors may play a role in the etiology of this malignancy. Differences between SEER and CNCPR findings emphasize the need for nationwide cancer surveillance.


Subject(s)
Liposarcoma , Databases, Factual , Female , Humans , Incidence , Liposarcoma/epidemiology , Male , Registries , Research Design , United States/epidemiology
4.
Exp Cell Res ; 355(2): 153-161, 2017 06 15.
Article in English | MEDLINE | ID: mdl-28390677

ABSTRACT

Transport of therapeutic agents across epithelial barriers is an important element in drug delivery. Transepithelial flux is widely used as a measure of transit across an epithelium, however it is most typically employed as a relative as opposed to absolute measure of molecular movement. Here, we have used the calcium switch approach to measure the maximum rate of paracellular flux through unencumbered intercellular junctions as a method to calibrate the flux rates for a series of tracers ranging in 0.6-900kDa in size across barriers composed of human colon epithelial (Caco-2) cells. We then examined the effects of nanostructured films (NSFs) on transepithelial transport. Two different NSF patterns were used, Defined Nanostructure (DN) 2 imprinted on polypropylene (PP) and DN3 imprinted on polyether ether ketone (PEEK). NSFs made direct contact with cells and decreased their barrier function, as measured by transepithelial resistance (TER), however cell viability was not affected. When NSF-induced transepithelial transport of Fab fragment (55kDa) and IgG (160kDa) was measured, it was unexpectedly found to be significantly greater than the maximum paracellular rate as predicted using cells cultured in low calcium. These data suggested that NSFs stimulate an active transport pathway, most likely transcytosis, in addition to increasing paracellular flux. Transport of IgG via transcytosis was confirmed by immunofluorescence confocal microscopy, since NSFs induced a significant level of IgG endocytosis by Caco-2 cells. Thus, NSF-induced IgG flux was attributable to both transcytosis and the paracellular route. These data provide the first demonstration that transcytosis can be stimulated by NSFs and that this was concurrent with increased paracellular permeability. Moreover, NSFs with distinct architecture paired with specific substrates have the potential to provide an effective means to regulate transepithelial transport in order to optimize drug delivery.


Subject(s)
Epithelial Cells/drug effects , Epithelium/drug effects , Epithelium/metabolism , Nanostructures/chemistry , Transcytosis/drug effects , Caco-2 Cells , Cell Line, Tumor , Drug Delivery Systems , Humans , Surface Properties
5.
Childs Nerv Syst ; 31(11): 2111-6, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26243160

ABSTRACT

PURPOSE: With the increase in knowledge and management of sport-related concussion over the last 15 years, there has been a shift from a grading scale approach to an individualized management approach. As a result, there is an increased need to better understand the factors involved in delayed recovery of concussion. The purpose of this retrospective study was to examine factors that may be associated with recovery from sport-related concussion in student athletes aged 11 to 18 years old. METHODS: Of the 366 patients who met the inclusion criteria, 361 were included in our analysis. The primary dependent variable included days until athlete was able to return to play (RTP). Independent variables of interest included age, gender, academic performance, comorbid factors, sports, on-field markers, days until initial neurological evaluation, Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT®) scores, acute headache rescue medications, chronic headache medication, sleep medication, and referral to concussion rehabilitation program. RESULTS: Variables associated with longer median RTP were being female (35 days), having a referral to concussion rehabilitation program (53 days), being prescribed acute headache rescue therapy (34 days), and having chronic headache treatment (53 days) (all p < 0.05). Variables associated with shorter RTP were on-field marker of headache (23 days) and evaluation within 1 week of concussion by a concussion specialist (16 days) (Both p < 0.05). CONCLUSION: This study supports the need for a concussed athlete to have access to a provider trained in concussion management in a timely fashion in order to prevent delayed recovery and return to play.


Subject(s)
Athletic Injuries/complications , Brain Concussion/etiology , Brain Concussion/therapy , Recovery of Function/physiology , Adolescent , Child , Female , Humans , Intensive Care Units, Pediatric , Male , Neuropsychological Tests , Retrospective Studies , Risk Factors , Severity of Illness Index , Statistics, Nonparametric , Time Factors
6.
Nano Lett ; 15(4): 2434-41, 2015 Apr 08.
Article in English | MEDLINE | ID: mdl-25790174

ABSTRACT

Transdermal delivery of therapeutics is restricted by narrow limitations on size and hydrophobicity. Nanotopography has been shown to significantly enhance high molecular weight paracellular transport in vitro. Herein, we demonstrate for the first time that nanotopography applied to microneedles significantly enhances transdermal delivery of etanercept, a 150 kD therapeutic, in both rats and rabbits. We further show that this effect is mediated by remodeling of the tight junction proteins initiated via integrin binding to the nanotopography, followed by phosphorylation of myosin light chain (MLC) and activation of the actomyosin complex, which in turn increase paracellular permeability.


Subject(s)
Etanercept/administration & dosage , Etanercept/pharmacokinetics , Integrins/metabolism , Microinjections/instrumentation , Needles , Skin Absorption/physiology , Administration, Cutaneous , Caco-2 Cells , Equipment Design , Equipment Failure Analysis , Humans , Materials Testing , Molecular Weight , Nanotechnology/instrumentation , Nanotechnology/methods , Surface Properties
7.
Tissue Eng Part A ; 20(1-2): 130-8, 2014 Jan.
Article in English | MEDLINE | ID: mdl-23914986

ABSTRACT

Understanding and modulating the cellular response to implanted biomaterials is crucial for the field of tissue engineering and regenerative medicine. Since cells typically reside in an extracellular matrix containing nanoscale architecture, identifying synthetic nanostructures that induce desirable cellular behaviors could greatly impact the field. Using nanoimprint lithography, nanostructured patterns were generated on thin film polymeric materials. The ability of these surfaces to influence protein adsorption, fibroblast proliferation and morphology, and fibrotic markers was investigated. Nanostructured features with aspect ratios greater than five allowed for less protein adsorption, resulting in decreased fibroblast proliferation and rounded cellular morphology. These nanofeatures also induced significantly lower gene expression of collagen 1α2, collagen 3α1, and growth factors such as connective tissue growth factor, integrin linked kinase, transforming growth factor ß1 (TGF-ß1), and epidermal growth factor, key factors associated with a fibrotic response. The results demonstrate that select nanostructured surfaces could be used to modulate the fibrotic behavior in cells and have the potential to be used as antifibrotic architecture for medical implants or tissue engineering scaffolds.


Subject(s)
Fibroblasts/pathology , Nanoparticles/chemistry , Proteins/metabolism , Adsorption , Animals , Cell Proliferation , Cell Shape , Fibrinogen/metabolism , Fibroblasts/drug effects , Fibroblasts/ultrastructure , Fibrosis , Fluorescein-5-isothiocyanate/metabolism , Gene Expression Regulation , Immunoglobulin G/metabolism , Mice , Molecular Imprinting , NIH 3T3 Cells , Polypropylenes/chemistry , Polystyrenes/chemistry , Serum Albumin, Bovine/metabolism , Water/chemistry
8.
Nano Lett ; 13(1): 164-71, 2013 Jan 09.
Article in English | MEDLINE | ID: mdl-23186530

ABSTRACT

Herein, we demonstrate that nanotopographical cues can be utilized to enable biologics >66 kDa to be transported across epithelial monolayers. When placed in contact with epithelial monolayers, nanostructured thin films loosen the epithelial barrier and allow for significantly increased transport of FITC-albumin, FITC-IgG, and a model therapeutic, etanercept. Our work highlights the potential to use drug delivery systems which incorporate nanotopography to increase the transport of biologics across epithelial tissue.


Subject(s)
Biological Products/pharmacokinetics , Epithelium/metabolism , Nanostructures , Albumins/pharmacokinetics , Immunoglobulin G/metabolism , Permeability
SELECTION OF CITATIONS
SEARCH DETAIL
...